Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial

Keith B. Allen, Robert D. Dowling, Douglas R. Schuch, Thomas A. Pfeffer, Steven Marra, Edward A. Lefrak, Tommy L. Fudge, Mark Mostovych, Szabolc Szentpetery, Sibu P. Saha, Douglas Murphy, Hugh Dennis

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background In a prospective, randomized trial involving 263 patients who would be incompletely revascularized by coronary artery bypass grafting (CABG) alone, CABG plus transmyocardial revascularization (CABG/TMR) provided an early mortality benefit with similar angina relief compared with CABG alone at 1 year. We evaluated the long-term outcome of patients randomized to CABG/TMR or CABG alone. Methods Thirteen centers that enrolled 83% (218/263) of the patients in the original trial participated in this longitudinal study. Between 1996 and 1998, these centers randomized 218 patients who would be incompletely revascularized by CABG alone because of diffusely diseased target vessels to either holmium:yttrium-aluminum-garnet (holmium:YAG) CABG/TMR (n = 110) or CABG alone (n = 108). Baseline demographics and operative characteristics were similar between groups. Follow-up (mean 5.0 ± 1.7 years) included survival and blinded angina class assessment. Results At this 5-year follow-up both groups experienced significant angina improvement from baseline, however, the CABG/TMR group had a lower mean angina score (0.4 ± 0.7 vs 0.7 ± 1.1, p = 0.05), a significantly lower proportion of patients with severe angina (class III/IV: 0% [0/68] vs 10% [6/60], p = 0.009), and a trend towards greater number of angina-free patients (78% [53/68] vs 63% [38/60], p = 0.08), compared with CABG alone patients. Kaplan-Meier survival at 6 years was similar between CABG/TMR and CABG alone patients (76% vs 80%, p = 0.90). Conclusions Five-year follow-up of prospectively randomized patients who would be incompletely revascularized because of diffuse coronary artery disease indicates that the addition of TMR to conventional CABG provides superior angina relief compared to CABG alone.

Original languageEnglish (US)
Pages (from-to)458-465
Number of pages8
JournalAnnals of Thoracic Surgery
Volume78
Issue number2
DOIs
StatePublished - Aug 1 2004

Fingerprint

Coronary Artery Bypass
Holmium
Survival
Longitudinal Studies
Coronary Artery Disease
Demography

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Allen, Keith B. ; Dowling, Robert D. ; Schuch, Douglas R. ; Pfeffer, Thomas A. ; Marra, Steven ; Lefrak, Edward A. ; Fudge, Tommy L. ; Mostovych, Mark ; Szentpetery, Szabolc ; Saha, Sibu P. ; Murphy, Douglas ; Dennis, Hugh. / Adjunctive transmyocardial revascularization : Five-year follow-up of a prospective, randomized trial. In: Annals of Thoracic Surgery. 2004 ; Vol. 78, No. 2. pp. 458-465.
@article{7a3ebbfb5cf949ad846f458e39ca0fa1,
title = "Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial",
abstract = "Background In a prospective, randomized trial involving 263 patients who would be incompletely revascularized by coronary artery bypass grafting (CABG) alone, CABG plus transmyocardial revascularization (CABG/TMR) provided an early mortality benefit with similar angina relief compared with CABG alone at 1 year. We evaluated the long-term outcome of patients randomized to CABG/TMR or CABG alone. Methods Thirteen centers that enrolled 83{\%} (218/263) of the patients in the original trial participated in this longitudinal study. Between 1996 and 1998, these centers randomized 218 patients who would be incompletely revascularized by CABG alone because of diffusely diseased target vessels to either holmium:yttrium-aluminum-garnet (holmium:YAG) CABG/TMR (n = 110) or CABG alone (n = 108). Baseline demographics and operative characteristics were similar between groups. Follow-up (mean 5.0 ± 1.7 years) included survival and blinded angina class assessment. Results At this 5-year follow-up both groups experienced significant angina improvement from baseline, however, the CABG/TMR group had a lower mean angina score (0.4 ± 0.7 vs 0.7 ± 1.1, p = 0.05), a significantly lower proportion of patients with severe angina (class III/IV: 0{\%} [0/68] vs 10{\%} [6/60], p = 0.009), and a trend towards greater number of angina-free patients (78{\%} [53/68] vs 63{\%} [38/60], p = 0.08), compared with CABG alone patients. Kaplan-Meier survival at 6 years was similar between CABG/TMR and CABG alone patients (76{\%} vs 80{\%}, p = 0.90). Conclusions Five-year follow-up of prospectively randomized patients who would be incompletely revascularized because of diffuse coronary artery disease indicates that the addition of TMR to conventional CABG provides superior angina relief compared to CABG alone.",
author = "Allen, {Keith B.} and Dowling, {Robert D.} and Schuch, {Douglas R.} and Pfeffer, {Thomas A.} and Steven Marra and Lefrak, {Edward A.} and Fudge, {Tommy L.} and Mark Mostovych and Szabolc Szentpetery and Saha, {Sibu P.} and Douglas Murphy and Hugh Dennis",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/j.athoracsur.2004.04.049",
language = "English (US)",
volume = "78",
pages = "458--465",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

Allen, KB, Dowling, RD, Schuch, DR, Pfeffer, TA, Marra, S, Lefrak, EA, Fudge, TL, Mostovych, M, Szentpetery, S, Saha, SP, Murphy, D & Dennis, H 2004, 'Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial', Annals of Thoracic Surgery, vol. 78, no. 2, pp. 458-465. https://doi.org/10.1016/j.athoracsur.2004.04.049

Adjunctive transmyocardial revascularization : Five-year follow-up of a prospective, randomized trial. / Allen, Keith B.; Dowling, Robert D.; Schuch, Douglas R.; Pfeffer, Thomas A.; Marra, Steven; Lefrak, Edward A.; Fudge, Tommy L.; Mostovych, Mark; Szentpetery, Szabolc; Saha, Sibu P.; Murphy, Douglas; Dennis, Hugh.

In: Annals of Thoracic Surgery, Vol. 78, No. 2, 01.08.2004, p. 458-465.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adjunctive transmyocardial revascularization

T2 - Five-year follow-up of a prospective, randomized trial

AU - Allen, Keith B.

AU - Dowling, Robert D.

AU - Schuch, Douglas R.

AU - Pfeffer, Thomas A.

AU - Marra, Steven

AU - Lefrak, Edward A.

AU - Fudge, Tommy L.

AU - Mostovych, Mark

AU - Szentpetery, Szabolc

AU - Saha, Sibu P.

AU - Murphy, Douglas

AU - Dennis, Hugh

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Background In a prospective, randomized trial involving 263 patients who would be incompletely revascularized by coronary artery bypass grafting (CABG) alone, CABG plus transmyocardial revascularization (CABG/TMR) provided an early mortality benefit with similar angina relief compared with CABG alone at 1 year. We evaluated the long-term outcome of patients randomized to CABG/TMR or CABG alone. Methods Thirteen centers that enrolled 83% (218/263) of the patients in the original trial participated in this longitudinal study. Between 1996 and 1998, these centers randomized 218 patients who would be incompletely revascularized by CABG alone because of diffusely diseased target vessels to either holmium:yttrium-aluminum-garnet (holmium:YAG) CABG/TMR (n = 110) or CABG alone (n = 108). Baseline demographics and operative characteristics were similar between groups. Follow-up (mean 5.0 ± 1.7 years) included survival and blinded angina class assessment. Results At this 5-year follow-up both groups experienced significant angina improvement from baseline, however, the CABG/TMR group had a lower mean angina score (0.4 ± 0.7 vs 0.7 ± 1.1, p = 0.05), a significantly lower proportion of patients with severe angina (class III/IV: 0% [0/68] vs 10% [6/60], p = 0.009), and a trend towards greater number of angina-free patients (78% [53/68] vs 63% [38/60], p = 0.08), compared with CABG alone patients. Kaplan-Meier survival at 6 years was similar between CABG/TMR and CABG alone patients (76% vs 80%, p = 0.90). Conclusions Five-year follow-up of prospectively randomized patients who would be incompletely revascularized because of diffuse coronary artery disease indicates that the addition of TMR to conventional CABG provides superior angina relief compared to CABG alone.

AB - Background In a prospective, randomized trial involving 263 patients who would be incompletely revascularized by coronary artery bypass grafting (CABG) alone, CABG plus transmyocardial revascularization (CABG/TMR) provided an early mortality benefit with similar angina relief compared with CABG alone at 1 year. We evaluated the long-term outcome of patients randomized to CABG/TMR or CABG alone. Methods Thirteen centers that enrolled 83% (218/263) of the patients in the original trial participated in this longitudinal study. Between 1996 and 1998, these centers randomized 218 patients who would be incompletely revascularized by CABG alone because of diffusely diseased target vessels to either holmium:yttrium-aluminum-garnet (holmium:YAG) CABG/TMR (n = 110) or CABG alone (n = 108). Baseline demographics and operative characteristics were similar between groups. Follow-up (mean 5.0 ± 1.7 years) included survival and blinded angina class assessment. Results At this 5-year follow-up both groups experienced significant angina improvement from baseline, however, the CABG/TMR group had a lower mean angina score (0.4 ± 0.7 vs 0.7 ± 1.1, p = 0.05), a significantly lower proportion of patients with severe angina (class III/IV: 0% [0/68] vs 10% [6/60], p = 0.009), and a trend towards greater number of angina-free patients (78% [53/68] vs 63% [38/60], p = 0.08), compared with CABG alone patients. Kaplan-Meier survival at 6 years was similar between CABG/TMR and CABG alone patients (76% vs 80%, p = 0.90). Conclusions Five-year follow-up of prospectively randomized patients who would be incompletely revascularized because of diffuse coronary artery disease indicates that the addition of TMR to conventional CABG provides superior angina relief compared to CABG alone.

UR - http://www.scopus.com/inward/record.url?scp=3242792417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242792417&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2004.04.049

DO - 10.1016/j.athoracsur.2004.04.049

M3 - Article

C2 - 15276496

AN - SCOPUS:3242792417

VL - 78

SP - 458

EP - 465

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -